Nebido testosterone to take centre stage in hypogonadism?

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1623, 2008-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism

By Harle Lindsey Basaria Shehzad Dobs Adrian S

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1751-1759

Informa Healthcare

Access to resources Recommend Favorite

Saxagliptin set to take the stage for glycaemic control?

Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Testosterone abuse: Fatal pulmonary peliosis?: case report

Reactions Weekly, Vol. 1, Iss. 1289, 2010-01 ,pp. : 40-40

Adis International

Access to resources Recommend Favorite

Testosterone replacement therapy: what are the risks?

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Testosterone undecanoate: effective contraceptive for Chinese men?

Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite